4 critical circumstances of surprising blood clots with a low platelet depend have been reported.
The European Union’s drug regulator stated on Friday it had launched an examination of doable hyperlinks between Johnson & Johnson’s coronavirus vaccine and blood clots following studies of 4 circumstances, certainly one of them deadly.
The European Medicines Company (EMA) stated its security committee “has began the evaluate of a security sign to guage studies of thromboembolic occasions” with individuals who had obtained the vaccine.
“4 critical circumstances of surprising blood clots with low platelets have been reported after vaccination with the Janssen covid-19 vaccine,” the EMA stated, referring to the European subsidiary of US pharmaceutical big J&J.
“One case occurred in a medical trial and three circumstances occurred throughout the deployment of the vaccine in the USA. Certainly one of them was deadly, “he added.
The EMA permitted the usage of Johnson & Johnson’s vaccine, however its rollout in all 27 EU nations is not going to start till the tip of this month. (I)